Secondary amyloidosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 23: Line 23:
|-
|-
|
|
* [[Syndrome of inappropriate antidiuretic hormone|SIADH]]<ref name="Raftopoulos2007">{{cite journal|last1=Raftopoulos|first1=Harry|title=Diagnosis and management of hyponatremia in cancer patients|journal=Supportive Care in Cancer|volume=15|issue=12|year=2007|pages=1341–1347|issn=0941-4355|doi=10.1007/s00520-007-0309-9}}</ref>
*  
|
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
*  


*  
*  
|-
|-
|
|
* [[Ectopic]] [[ACTH]] [[secretion]]<ref name="BarbosaRodien2005">{{cite journal|last1=Barbosa|first1=Sandrine Laboureau-Soares|last2=Rodien|first2=Patrice|last3=Leboulleux|first3=Sophie|last4=Niccoli-Sire|first4=Patricia|last5=Kraimps|first5=Jean-Louis|last6=Caron|first6=Philippe|last7=Archambeaud-Mouveroux|first7=Françoise|last8=Conte-Devolx|first8=Bernard|last9=Rohmer|first9=Vincent|title=Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature|journal=Thyroid|volume=15|issue=6|year=2005|pages=618–623|issn=1050-7256|doi=10.1089/thy.2005.15.618}}</ref>
*  
|
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]], [[medullary carcinoma of the thyroid]] and other [[Cancer|cancers]]
*  
|-
|-
|
|
* [[Tumor induced osteomalacia]]<ref name="FlorenzanoGafni2017">{{cite journal|last1=Florenzano|first1=Pablo|last2=Gafni|first2=Rachel I.|last3=Collins|first3=Michael T.|title=Tumor-induced osteomalacia|journal=Bone Reports|volume=7|year=2017|pages=90–97|issn=23521872|doi=10.1016/j.bonr.2017.09.002}}</ref>
*  
|
|
* [[Metastatic]] [[breast cancer]]
*  


*  
*  
|-
|-
|
|
* [[Hypoglycemia]]<ref name="NauckReinecke2007">{{cite journal|last1=Nauck|first1=Michael A.|last2=Reinecke|first2=Manfred|last3=Perren|first3=Aurel|last4=Frystyk|first4=Jan|last5=Berishvili|first5=Giorgi|last6=Zwimpfer|first6=Cornelia|last7=Figge|first7=Anja M.|last8=Flyvbjerg|first8=Allan|last9=Lankisch|first9=Paul G.|last10=Blum|first10=Werner F.|last11=Klöppel|first11=Günter|last12=Schmiegel|first12=Wolff|last13=Zapf|first13=Jürgen|title=Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I in a Patient with Metastasizing Large-Cell Carcinoma of the Lung|journal=The Journal of Clinical Endocrinology & Metabolism|volume=92|issue=5|year=2007|pages=1600–1605|issn=0021-972X|doi=10.1210/jc.2006-2573}}</ref>
*  
|
|
* [[Gastrointestinal tract|GI]] cancers, [[mesothelioma]], [[lung]], [[real cancer]], and [[sarcomas]]
*  
|-
|-
| rowspan="6"  align="center" style="background:#f0f0f0;" |[[Mucocutaneous|Musculocutaneous]]
| rowspan="6"  align="center" style="background:#f0f0f0;" |
|
|
* [[Dermatomyositis]]<ref name="ThiersSahn2009">{{cite journal|last1=Thiers|first1=B. H.|last2=Sahn|first2=R. E.|last3=Callen|first3=J. P.|title=Cutaneous Manifestations of Internal Malignancy|journal=CA: A Cancer Journal for Clinicians|volume=59|issue=2|year=2009|pages=73–98|issn=0007-9235|doi=10.3322/caac.20005}}</ref>
|
|
* [[Breast cancer|Breast]], [[Ovarian cancer|ovarian]], [[Lung cancer|lung]], and [[prostate cancer]]
*  


*  
*  
|-
|-
|
|
* [[Leser-Trelat sign|Leser-Trélat sign]]<ref name="GaduputiChandrala2014">{{cite journal|last1=Gaduputi|first1=Vinaya|last2=Chandrala|first2=Chaitanya|last3=Tariq|first3=Hassan|last4=Kanneganti|first4=Kalyan|title=Sign of Leser-Trélat Associated with Esophageal Squamous Cell Cancer|journal=Case Reports in Oncological Medicine|volume=2014|year=2014|pages=1–3|issn=2090-6706|doi=10.1155/2014/825929}}</ref>
*  
|
|
* Gastrointestinal [[adenocarcinomas]] ([[Gastric adenocarcinoma|gastric]], [[Colon adenocarcinoma|colon]], rectal), [[breast cancer]], [[lymphoproliferative disorders]]/[[lymphoma]], and [[melanoma]].
*  


*  
*  
|-
|-
|
|
* [[Acanthosis nigricans]]<ref name="ThiersSahn2009">{{cite journal|last1=Thiers|first1=B. H.|last2=Sahn|first2=R. E.|last3=Callen|first3=J. P.|title=Cutaneous Manifestations of Internal Malignancy|journal=CA: A Cancer Journal for Clinicians|volume=59|issue=2|year=2009|pages=73–98|issn=0007-9235|doi=10.3322/caac.20005}}</ref>
*  
|
|
* [[Gastric adenocarcinoma]], [[endometrial cancer]].
*  


*  
*  
|-
|-
|
|
* [[Necrolytic migratory erythema]]<ref name="TremblayMarcil2017">{{cite journal|last1=Tremblay|first1=Catherine|last2=Marcil|first2=Isabelle|title=Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition|journal=Journal of Cutaneous Medicine and Surgery|volume=21|issue=6|year=2017|pages=559–561|issn=1203-4754|doi=10.1177/1203475417719051}}</ref>
*  
|
|
* [[Glucagonoma]]
*  


*  
*  
|-
|-
|
|
* [[Sweet's syndrome]]<ref name="CohenKurzrock1987">{{cite journal|last1=Cohen|first1=Philip R.|last2=Kurzrock|first2=Razelle|title=Sweet's syndrome and malignancy|journal=The American Journal of Medicine|volume=82|issue=6|year=1987|pages=1220–1226|issn=00029343|doi=10.1016/0002-9343(87)90229-4}}</ref>
*  
|
|
* [[Acute myeloid leukemia|Acute myelogenous leukemia]], [[Myeloproliferative disease|myeloproliferative disorders]], [[lymphoproliferative disorders]], [[myelodysplastic syndrome]], and [[carcinoma]]
*  


*  
*  
|-
|-
|
|
* [[Pyoderma gangrenosum]]<ref name="YouJu2018">{{cite journal|last1=You|first1=Hye Rin|last2=Ju|first2=Jae-Kyun|last3=Yun|first3=Sook Jung|last4=Lee|first4=Jee-Bum|last5=Kim|first5=Seong-Jin|last6=Won|first6=Young Ho|last7=Lee|first7=Seung-Chul|title=Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma|journal=Annals of Dermatology|volume=30|issue=1|year=2018|pages=79|issn=1013-9087|doi=10.5021/ad.2018.30.1.79}}</ref>
*  
|
|
* [[Rectal Adenocarcinoma]], [[myeloproliferative disorders]], [[colon cancer]]
*  


*  
*  
Line 91: Line 90:
|+
|+
|-
|-
| rowspan="11"  align="center" style="background:#f0f0f0;" |[[Neurological]]<ref name="PelosofGerber2010">{{cite journal|last1=Pelosof|first1=Lorraine C.|last2=Gerber|first2=David E.|title=Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment|journal=Mayo Clinic Proceedings|volume=85|issue=9|year=2010|pages=838–854|issn=00256196|doi=10.4065/mcp.2010.0099}}</ref>
| rowspan="11"  align="center" style="background:#f0f0f0;" |
|
|
* [[Paraneoplastic cerebellar degeneration]]<ref name="AbdulazizYu2018">{{cite journal|last1=Abdulaziz|first1=Ammar Taha Abdullah|last2=Yu|first2=Xiao Qing|last3=Zhang|first3=Le|last4=Jiang|first4=Xin Yue|last5=Zhou|first5=Dong|last6=Li|first6=Jin Mei|title=Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism|journal=Medicine|volume=97|issue=24|year=2018|pages=e10717|issn=0025-7974|doi=10.1097/MD.0000000000010717}}</ref>
*  


|
|
Line 109: Line 108:
*  
*  
|
|
* [[Lung cancer]]
*  
*  
*  
|-
|-
Line 127: Line 126:
|-
|-
|
|
* [[Encephalitis]]
*  
|
|
* [[Teratoma]]
*  
|-
|-
|
|
* [[Polymyositis]]
*  
|
|
*  
*  
|-
|-
|
|
* [[Autonomic neuropathy]]<ref name="urlParaneoplastic autonomic neuropathy: a case report | GM">{{cite web |url=https://www.gmjournal.co.uk/paraneoplastic-autonomic-neuropathy-a-case-report |title=Paraneoplastic autonomic neuropathy: a case report &#124; GM |format= |work= |accessdate=}}</ref>
*  
|
|
* [[Carcinomas]],[[small cell lung cancer]], [[thymoma]]
*  
|-  
|-  
|
|
* [[Lambert-Eaton myasthenic syndrome]] ([[LEMS]])
*  
|
|
* [[Small cell lung cancer|Small-cell lung cancer]], [[prostate cancer]], [[lymphomas]], [[adenocarcinomas]]
*  
|-
|-
|
|
* [[Myasthenia gravis]]
*  
|
|
* [[Thymoma]]
*  
|-
|-
|
|

Revision as of 19:32, 4 November 2019

link=https://www.wikidoc.org/index.php/Secondary amyloidosis#Overview
link=https://www.wikidoc.org/index.php/Secondary amyloidosis#Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.

Differentiating Amyloidosis from other Diseases

Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.


References